Patents by Inventor Mickey Pentecost
Mickey Pentecost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230312678Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.Type: ApplicationFiled: November 16, 2022Publication date: October 5, 2023Applicant: DIADEM BIOTHERAPEUTICS INC.Inventors: Mickey Pentecost, Wojciech Bartkowski
-
Patent number: 11746138Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.Type: GrantFiled: July 16, 2021Date of Patent: September 5, 2023Assignee: DIADEM BIOTHERAPEUTICS INC.Inventors: Mickey Pentecost, Wojciech Bartkowski
-
Patent number: 11578116Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.Type: GrantFiled: July 16, 2021Date of Patent: February 14, 2023Assignee: DIADEM BIOTHERAPEUTICS INC.Inventors: Mickey Pentecost, Wojciech Bartkowski
-
Publication number: 20220411481Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.Type: ApplicationFiled: August 9, 2021Publication date: December 29, 2022Applicant: DIADEM BIOTHERAPEUTICS INC.Inventors: Mickey Pentecost, Wojciech Bartkowski
-
Publication number: 20210379198Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.Type: ApplicationFiled: July 16, 2021Publication date: December 9, 2021Applicant: DIADEM BIOTHERAPEUTICS INC.Inventors: Mickey Pentecost, Wojciech Bartkowski
-
Publication number: 20210371497Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.Type: ApplicationFiled: July 16, 2021Publication date: December 2, 2021Applicant: DIADEM BIOTHERAPEUTICS INC.Inventors: Mickey Pentecost, Wojciech Bartkowski
-
Publication number: 20190046576Abstract: Provided herein are lyophilized compositions containing the secretome of cultured adipose cells, pharmaceutical compositions and that additionally contain a sustained release drug delivery matrix, as well as methods of making and using such compositions.Type: ApplicationFiled: February 13, 2017Publication date: February 14, 2019Applicant: Cell Care TherapeuticsInventors: Raja Shekhar Gangaraju, Nicolas Miroslav Jotterand Sohl, Veronique Hedwige Jotterand, Mickey Pentecost